Hammertoe Market
is presumed to demonstrate 10.8% CAGR during the forecast period (2018-2023) owing to the increasing incidences of arthritis, asserts Market Research Future (MRFR). The market touched a valuation of 172.51 USD million in 2018 and is estimated to garner 288.61 USD million by the end of 2023. Hammertoe is referred to as a feet-related disorder where the feet bends permanently. Hammertoe occurs due to an imbalance in the muscles and the ligaments which holds the toe straight. It usually occurs while wearing narrow shoes or small-size shoes. Muscle or vein damage, osteoarthritis, rheumatoid arthritis, Charcot–Marie–Tooth disease, stroke, and other feet problems are some of the major reasons causing hammertoe. While in some cases, hammertoe in an individual may occur since birth, it usually occurs due to wrong selection of shoes.
Request Sample Copy:
https://www.marketresearchfuture.com/sample_request/4172
With rising incidences of arthritis among the population, the global hammertoe market is considered to flourish during the assessment period. Arthritis is one of the most common joint related problems which generally occurs due to increasing age and osteoporosis and is one of the major reasons for hammertoe. For instance, as per the Centers for Disease Control and Prevention, on February 2018, around 54.4 million of the total population has been diagnosed with arthritis, in which 18.1% were men and 23.4% were women. Moreover, with increasing expenditure on research and development activities in the healthcare industry, the hammertoe market is likely to boom during the appraisal period. With growing bones related and hammertoe problems across the world, the need for advanced healthcare services is increasing.
Competitive Dashboard
The prominent players operating the global hammertoe market are Stryker (U.S), Smith & Nephew (U.K), Zimmer Biomet Holdings (U.S), Extremity Medical LLC (U.S), Nextremity Solutions Inc. (U.S), Arrowhead Medical Device Technologies LLC (Tennessee), Wright Medical Group N.V. (Memphis, TN), BioPro (Michigan).
Global Hammertoe Market: Segmental Analysis
The global hammertoe market has been segmented on the basis of type, treatment and diagnosis, end-user, and region.
By mode of type, the hammertoe market has been segmented into flexible and rigid. The joints in the toe can be straightened and moved in case of flexible hammertoe. Flexible hammertoes cause irritation and pain can lead to the development of calluses and corns. On the other hand, the rigid hammertoes lose their flexibility, and the joints are immovable. The tendons become as tight that the interphalangeal joint becomes misaligned and immobile. It has been estimated that the rigid hammertoe exhibits 10.8% CAGR, while the flexible hammertoes exhibit 8.3% CAGR.
By mode of end-users, the hammertoe market has been segmented into physiotherapy and orthopedic centers, hospitals and clinics, and others. Among these, the hospital segment is considered to dominate the market owing to the rapid adoption of new procedures and technologies in order to offer effective services.
Regional Insights
Geographically, the hammertoe market span across regions namely, Europe, Americas, Asia Pacific, and the Middle East and Africa.
Within the Americas, the North American region is considered to be a pioneer in foot and ankle surgery and holds the largest market share in the global hammertoe market. The growth in this region is attributed to the availability of top-class healthcare infrastructure, rapid adoption of new products and treatments, and advanced medical facilities. Moreover, the availability of skilled health professionals, high purchasing power of patients, and availability of products are contributing to the market growth. Additionally, top players operating from this region are encouraging innovation and new product developments, thereby influencing the market growth during the assessment period.
The Asia Pacific region is considered to be the fastest growing region owing to the rapidly developing economy, increasing awareness of new treatments and products, and changing healthcare sector. Several initiatives taken by the government to improve public health is also driving the global hammertoe market. With the rising geriatric population and accident cases, the market is likely to foster in the coming years.
Browse Complete Report Details @
https://www.marketresearchfuture.com/reports/hammertoe-market-4172
NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: [email protected]
The report includes basic information along with advanced market statistics of the global Hammertoe market.
Accurate information about the market dynamics along with future growth prospects are analyzed in the report.
Data experts analyze the market information and come up with detailed insights revealing operating margins, competitive landscape, key industry trends and the factors impacting the global Hammertoe market.
Different strategies undertaken by market players in order to get a competitive advantage over their competitors and increase their global market reach are also studied comprehensively in the report.The chapter on market dynamics includes market drivers, restraints, and opportunities which help familiarize with market potential and upcoming opportunities.
The chapter on key insights includes emerging trends from major countries, latest technological advancement, regulatory landscape, SWOT analysis, and porters five forces analysis.
The chapter on competitive analysis includes profiling of leading companies in the global market to map the leading companies and their focus of interest in the market.For More Enquiry and Discount related quarries @ https://www.datalibraryresearch.com/enquiry/hammertoe-market-2164SegmentationThe global Hammertoe market has been segmented on the basis of production, region, market share and so on.
The global hammertoe market was valued at USD 172.51 Mn in 2018 and is expected to catapult to a market valuation of USD 288.61 Mn by the end of 2023.
Market Research Future (MRFR) perceives the global hammertoe market to showcase an impressive CAGR of 10.8% over the forecast period of 2018-2023.
Request Sample Copy:https://www.marketresearchfuture.com/sample_request/4172SegmentationThe global hammertoe market has been segmented based on type, treatment and diagnosis, and end user.
The surgery segment is likely to dominate the market.The diagnosis segment has been further segmented into x-rays, physical examinations, and others.
By end user, the global hammertoe market has been segmented into physiotherapy and orthopedic centers, hospitals and clinics, and others.
Advanced medical facilities, availability of skilled healthcare professionals, high healthcare expenditure and availability of predicts are boosting the growth of the market in the region.
Global Hammertoe Market Research Report: Information by Type (Rigid and Flexible), Treatment & Diagnosis (Treatment and Diagnosis), End User (Hospitals & Clinics and Physiotherapy & Orthopedic Centers) and Region (North America, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2027Market InsightsHammertoe is a foot problem where the feet are constantly bent.
The problem is caused due to an imbalance of the ligaments and muscles that hold the finger tight.
The growing prevalence of arthritis and the increasing spending on R in the health sector stimulate market growth.
Factors such as complications and pain associated with surgical procedures, the risk of infections during surgical treatments, hospitalizations, and lack of awareness should hinder the market growth.The prevalence of arthritis increased in February 2018.
As a result, the increasing prevalence of arthritis in the population will stimulate market growth.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/4172Market SegmentationThe global hammertoe market is broadly bifurcated based on type, treatment & diagnosis, and end-user.Based on the type, the worldwide hammertoe market is divided into a rigid type and a flexible type.
According to Andrew Park, senior director of orthopedics at iDATA Research, global medical devices and company said 648,000 hammertoe surgeries were performed in the United States in 2017.The global hammertoe market is also bifurcated into treatment and diagnosis.
According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.
The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.
Click here to know more on Non-Small Cell Lung Cancer pipeline NSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many othersKey Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.Market DriverMarket Barrier The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.Detailed Non-Small Cell Lung Cancer market size by therapies, covering the United States, EU5 and Japan from 2017-2030.Reimbursement scenario and Key Opinion Leader Views Table of ContentsKey InsightsExecutive Summary of NSCLCSWOT Analysis of NSCLCNSCLC: Market Overview at a Glance4.1.
Total Market size of NSCLC in JapanALK-Mutation—Market Size21.1.
Report MethodologyDelveInsight CapabilitiesDisclaimerAbout DelveInsight Request a Webex Demo to get a walk-through of the report: https://www.delveinsight.com/sample-request/non-small-cell-lung-cancer-marketRelated Reports:Non-Small Cell Lung Cancer Epidemiology Forecast to 2030Non-Small Cell Lung Cancer Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020Non-Small Cell Lung Cancer Pipeline Insights, 2020About DelveInsightDelveInsight is a premier Business Consulting and Market Research firm, focused exclusively on the life science segment.
